WASHINGTON, D.C.—The U.S. Senate Committee on Commerce, Science, and Transportation will hold a hearing examining the so-called “gray market” drug companies who drive up the cost of short-supply prescription drugs. The hearing will explore how and why hospitals and other health care providers sometimes struggle to obtain short-supply prescription drugs they need to treat patients suffering from cancer and other life-threatening conditions. This hearing is the result of a joint Congressional investigation by Chairman John D. (Jay) Rockefeller IV, Senator Tom Harkin, Chairman of the Senate Committee on Health, Education, Labor, and Pensions, and Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform.
Please note the hearing will be webcast live via the Senate Commerce Committee website. Refresh the Commerce Committee homepage 10 minutes prior to the scheduled start time to automatically begin streaming the webcast.
Individuals with disabilities who require an auxiliary aid or service, including closed captioning service for webcast hearings, should contact Collenne Wider at 202-224-5511 at least three business days in advance of the hearing date.
###
Committee Members
-
John Rockefeller
Chairman
Testimony
-
Elijah E. Cummings
Ranking MemberU.S. House Committee on Oversight and Government Reform
Witness Panel 2
-
Virginia Herold
-
David Mayhaus
-
John Coster
Senior Vice President of Government Affairs and Director, NCPA Advocacy CenterNational Community Pharmacists Association -
John Gray
-
Patricia Earl